LSB
LakeShore Biopharma Co Ltd
$
1.180
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.230
Open
1.100
VWAP
1.14
Vol
128.22K
Mkt Cap
48.63M
Low
1.070
Amount
146.07K
EV/EBITDA(TTM)
--
Total Shares
41.21M
EV
88.10M
EV/OCF(TTM)
--
P/S(TTM)
0.17
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Show More
Valuation Metrics
The current forward P/E ratio for LakeShore Biopharma Co Ltd (LSB.O) is -0.44, compared to its 5-year average forward P/E of -1.40. For a more detailed relative valuation and DCF analysis to assess LakeShore Biopharma Co Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-1.40
Current PE
-0.44
Overvalued PE
-0.04
Undervalued PE
-2.77
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-32.58
Current EV/EBITDA
-33.39
Overvalued EV/EBITDA
12.40
Undervalued EV/EBITDA
-77.56
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.56
Current PS
0.18
Overvalued PS
1.12
Undervalued PS
-0.01
Financials
Annual
Quarterly
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
LSB News & Events
Events Timeline
2024-12-12 (ET)
2024-12-12
19:00:12
LakeShore Biopharma provides update on ongoing investigation involving Yi Zhang
2024-10-29 (ET)
2024-10-29
08:40:50
LakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirement
2024-10-25 (ET)
2024-10-25
08:33:40
LakeShore's YSJA rabies vaccine receives approval for Phase III trial in China
Sign Up For More Events
Sign Up For More Events
News
8.5
07-09BenzingaWhy AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
8.5
07-08NewsfilterLakeShore Biopharma Announces US$15 Million Private Placement Financing
8.5
07-08SeekingAlphaLakeShore Biopharma announces $15M private placement financing
Sign Up For More News
People Also Watch
NVNI
Nvni Group Ltd
0.381
USD
-7.07%
SSBI
Summit State Bank
11.750
USD
+0.51%
MDIA
Mediaco Holding Inc
1.220
USD
-0.81%
CELU
Celularity Inc
3.740
USD
+18.73%
FBIO
Fortress Biotech Inc
1.970
USD
+4.23%
CLST
Catalyst Bancorp Inc
12.270
USD
-1.68%
KSCP
Knightscope Inc
7.510
USD
-13.18%
BEDU
Bright Scholar Education Holdings Ltd
1.815
USD
+1.97%
BEST
BEST Inc
2.800
USD
-0.72%
OPI
Office Properties Income Trust
0.251
USD
+2.04%
FAQ
What is LakeShore Biopharma Co Ltd (LSB) stock price today?
The current price of LSB is 1.18 USD — it has increased 9.26 % in the last trading day.
What is LakeShore Biopharma Co Ltd (LSB)'s business?
What is the price predicton of LSB Stock?
What is LakeShore Biopharma Co Ltd (LSB)'s revenue for the last quarter?
What is LakeShore Biopharma Co Ltd (LSB)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for LakeShore Biopharma Co Ltd (LSB)'s fundamentals?
How many employees does LakeShore Biopharma Co Ltd (LSB). have?